Francine Shapiro1. 1. Senior Research Fellow Emeritus at the Mental Research Institute, the Creator of EMDR Therapy, the Executive Director of the EMDR Institute, and the Founder of the nonprofit EMDR Humanitarian Assistance Programs in Hamden, CT. fshapiro@mcn.org.
Abstract
BACKGROUND: A substantial body of research shows that adverse life experiences contribute to both psychological and biomedical pathology. Eye movement desensitization and reprocessing (EMDR) therapy is an empirically validated treatment for trauma, including such negative life experiences as commonly present in medical practice. The positive therapeutic outcomes rapidly achieved without homework or detailed description of the disturbing event offer the medical community an efficient treatment approach with a wide range of applications. METHODS: All randomized studies and significant clinical reports related to EMDR therapy for treating the experiential basis of both psychological and somatic disorders are reviewed. Also reviewed are the recent studies evaluating the eye movement component of the therapy, which has been posited to contribute to the rapid improvement attributable to EMDR treatment. RESULTS: Twenty-four randomized controlled trials support the positive effects of EMDR therapy in the treatment of emotional trauma and other adverse life experiences relevant to clinical practice. Seven of 10 studies reported EMDR therapy to be more rapid and/or more effective than trauma-focused cognitive behavioral therapy. Twelve randomized studies of the eye movement component noted rapid decreases in negative emotions and/or vividness of disturbing images, with an additional 8 reporting a variety of other memory effects. Numerous other evaluations document that EMDR therapy provides relief from a variety of somatic complaints. CONCLUSION: EMDR therapy provides physicians and other clinicians with an efficient approach to address psychological and physiologic symptoms stemming from adverse life experiences. Clinicians should therefore evaluate patients for experiential contributors to clinical manifestations.
BACKGROUND: A substantial body of research shows that adverse life experiences contribute to both psychological and biomedical pathology. Eye movement desensitization and reprocessing (EMDR) therapy is an empirically validated treatment for trauma, including such negative life experiences as commonly present in medical practice. The positive therapeutic outcomes rapidly achieved without homework or detailed description of the disturbing event offer the medical community an efficient treatment approach with a wide range of applications. METHODS: All randomized studies and significant clinical reports related to EMDR therapy for treating the experiential basis of both psychological and somatic disorders are reviewed. Also reviewed are the recent studies evaluating the eye movement component of the therapy, which has been posited to contribute to the rapid improvement attributable to EMDR treatment. RESULTS: Twenty-four randomized controlled trials support the positive effects of EMDR therapy in the treatment of emotional trauma and other adverse life experiences relevant to clinical practice. Seven of 10 studies reported EMDR therapy to be more rapid and/or more effective than trauma-focused cognitive behavioral therapy. Twelve randomized studies of the eye movement component noted rapid decreases in negative emotions and/or vividness of disturbing images, with an additional 8 reporting a variety of other memory effects. Numerous other evaluations document that EMDR therapy provides relief from a variety of somatic complaints. CONCLUSION: EMDR therapy provides physicians and other clinicians with an efficient approach to address psychological and physiologic symptoms stemming from adverse life experiences. Clinicians should therefore evaluate patients for experiential contributors to clinical manifestations.
Authors: Mirjam J Nijdam; Berthold P R Gersons; Johannes B Reitsma; Ad de Jongh; Miranda Olff Journal: Br J Psychiatry Date: 2012-02-09 Impact factor: 9.319
Authors: Carlijn de Roos; Ricky Greenwald; Margien den Hollander-Gijsman; Eric Noorthoorn; Stef van Buuren; Ad de Jongh Journal: Eur J Psychotraumatol Date: 2011-04-06
Authors: Matthew Reeson; Wanda Polzin; Hannah Pazderka; Vincent Agyapong; Andrew J Greenshaw; Gary Hnatko; Yifeng Wei; Laurie Szymanski; Peter H Silverstone Journal: J Can Acad Child Adolesc Psychiatry Date: 2020-08-01
Authors: Samuel Offer; Elise Alexander; Kelsie Barbara; Erik Hemmingsson; Stuart W Flint; Blake J Lawrence Journal: Eat Weight Disord Date: 2022-07-30 Impact factor: 3.008
Authors: Amber N Edinoff; Tanner L Hegefeld; Murray Petersen; James C Patterson; Christopher Yossi; Jacob Slizewski; Ashley Osumi; Elyse M Cornett; Adam Kaye; Jessica S Kaye; Vijayakumar Javalkar; Omar Viswanath; Ivan Urits; Alan D Kaye Journal: Front Psychiatry Date: 2022-05-31 Impact factor: 5.435
Authors: Joseph A Boscarino; Richard E Adams; Tiah J Wingate; Joseph J Boscarino; Thomas G Urosevich; Stuart N Hoffman; H Lester Kirchner; Charles R Figley; William P Nash Journal: Front Psychiatry Date: 2022-06-06 Impact factor: 5.435
Authors: Ulrich Schnyder; Anke Ehlers; Thomas Elbert; Edna B Foa; Berthold P R Gersons; Patricia A Resick; Francine Shapiro; Marylène Cloitre Journal: Eur J Psychotraumatol Date: 2015-08-14
Authors: Cristina Trentini; Marco Pagani; Piercarlo Fania; Anna Maria Speranza; Giampaolo Nicolais; Alessandra Sibilia; Lucio Inguscio; Anna Rita Verardo; Isabel Fernandez; Massimo Ammaniti Journal: Front Psychol Date: 2015-11-05